NYSE:ZBH - Zimmer Biomet Stock Price, Forecast & News

Zimmer Biomet trades on the New York Stock Exchange (NYSE) under the ticker symbol "ZBH."

Zimmer Biomet declared a quarterly dividend on Tuesday, September 3rd. Investors of record on Monday, September 30th will be given a dividend of $0.24 per share on Thursday, October 31st. This represents a $0.96 dividend on an annualized basis and a dividend yield of 0.65%. The ex-dividend date is Friday, September 27th. View Zimmer Biomet's Dividend History.

Zimmer Biomet Holdings Inc (NYSE:ZBH) announced its earnings results on Tuesday, November, 5th. The medical equipment provider reported $1.77 EPS for the quarter, topping the Thomson Reuters' consensus estimate of $1.75 by $0.02. The medical equipment provider had revenue of $1.89 billion for the quarter, compared to the consensus estimate of $1.87 billion. Zimmer Biomet had a negative net margin of 1.14% and a positive return on equity of 13.71%. The company's revenue for the quarter was up 3.0% on a year-over-year basis. During the same period in the previous year, the business posted $1.63 earnings per share. View Zimmer Biomet's Earnings History.

Zimmer Biomet is scheduled to release their next quarterly earnings announcement on Friday, February 7th 2020. View Earnings Estimates for Zimmer Biomet.

Zimmer Biomet updated its FY19 earnings guidance on Tuesday, November, 5th. The company provided earnings per share guidance of $7.75 -7.90 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $7.82. The company issued revenue guidance of flat to +0.5% to ~$7.9-8.3 billion, compared to the consensus revenue estimate of $7.95 billion.

23 analysts have issued 1-year target prices for Zimmer Biomet's stock. Their forecasts range from $108.00 to $170.00. On average, they expect Zimmer Biomet's share price to reach $147.60 in the next twelve months. This suggests that the stock has a possible downside of 0.6%. View Analyst Price Targets for Zimmer Biomet.

23 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Zimmer Biomet in the last year. There are currently 1 sell rating, 4 hold ratings, 17 buy ratings and 1 strong buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Zimmer Biomet.

News stories about ZBH stock have trended very negative recently, InfoTrie reports. The research firm ranks the sentiment of press coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Zimmer Biomet earned a news sentiment score of -3.7 on InfoTrie's scale. They also gave media stories about the medical equipment provider a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the company's share price in the immediate future. View News Stories for Zimmer Biomet.

Some companies that are related to Zimmer Biomet include Intuitive Surgical (ISRG), Edwards Lifesciences (EW), COLOPLAST A/S/ADR (CLPBY), Align Technology (ALGN), Smith & Nephew (SNN), Steris (STE), DEMANT A S/ADR (WILYY), MSA Safety (MSA), Wright Medical Group (WMGI), Avanos Medical (AVNS), Inogen (INGN), Establishment Labs (ESTA), Sientra (SIEN), Invacare (IVC) and RTI Surgical (RTIX).

Based on aggregate information from My MarketBeat watchlists, some companies that other Zimmer Biomet investors own include AT&T (T), Cisco Systems (CSCO), Johnson & Johnson (JNJ), Celgene (CELG), UnitedHealth Group (UNH), Walt Disney (DIS), Visa (V), NVIDIA (NVDA), Bristol-Myers Squibb (BMY) and Chevron (CVX).

Zimmer Biomet's stock is owned by many different of institutional and retail investors. Top institutional shareholders include Massachusetts Financial Services Co. MA (5.38%), State Street Corp (4.04%), Boston Partners (1.88%), Wedge Capital Management L L P NC (0.47%), Focused Investors LLC (0.45%) and Sumitomo Mitsui Trust Holdings Inc. (0.39%). Company insiders that own Zimmer Biomet stock include Arthur J Higgins, Aure Bruneau, Betsy J Bernard, Bryan C Hanson, Chad F Phipps, Didier Deltort, Katarzyna Mazur-Hofsaess, Michael J Farrell, Michael W Michelson, Sang Yi, Syed A Jafry and Tony W Collins. View Institutional Ownership Trends for Zimmer Biomet.

ZBH stock was sold by a variety of institutional investors in the last quarter, including Massachusetts Financial Services Co. MA, Squarepoint Ops LLC, Man Group plc, Focused Investors LLC, Wedge Capital Management L L P NC, State of New Jersey Common Pension Fund D, State Street Corp and Rothschild Investment Corp IL. Company insiders that have sold Zimmer Biomet company stock in the last year include Aure Bruneau, Chad F Phipps, Didier Deltort and Sang Yi. View Insider Buying and Selling for Zimmer Biomet.

ZBH stock was bought by a variety of institutional investors in the last quarter, including Phoenix Holdings Ltd., California Public Employees Retirement System, Deroy & Devereaux Private Investment Counsel Inc., Voya Investment Management LLC, Douglas Lane & Associates LLC, Tamarack Advisers LP, Parametric Portfolio Associates LLC and Endurant Capital Management LP. Company insiders that have bought Zimmer Biomet stock in the last two years include Arthur J Higgins, Betsy J Bernard, Bryan C Hanson, Michael J Farrell, Michael W Michelson and Syed A Jafry. View Insider Buying and Selling for Zimmer Biomet.

Shares of ZBH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of ZBH stock can currently be purchased for approximately $148.53.

Zimmer Biomet has a market capitalization of $30.55 billion and generates $7.93 billion in revenue each year. The medical equipment provider earns $-379,200,000.00 in net income (profit) each year or $7.64 on an earnings per share basis. Zimmer Biomet employs 19,000 workers across the globe.View Additional Information About Zimmer Biomet.

The official website for Zimmer Biomet is http://www.zimmerbiomet.com/.

Zimmer Biomet's mailing address is 345 EAST MAIN STREET, WARSAW IN, 46580. The medical equipment provider can be reached via phone at 574-267-6131 or via email at [email protected]